NASDAQ:PIRS - Pieris Pharmaceuticals News Headlines

Sign in or create an account to add this stock to your watchlist.
$3.23 +0.16 (+5.21 %)
(As of 02/19/2019 03:50 PM ET)
Previous Close$3.07
Today's Range$3.01 - $3.28
52-Week Range$2.39 - $9.13
Volume25,389 shs
Average Volume370,022 shs
Market Capitalization$174.90 million
P/E Ratio-7.98
Dividend YieldN/A
Beta1.87

Headlines

Pieris Pharmaceuticals (NASDAQ PIRS) News Headlines

Source:
DateHeadline
Pieris Pharmaceuticals Inc (PIRS) Expected to Post Quarterly Sales of $6.92 MillionPieris Pharmaceuticals Inc (PIRS) Expected to Post Quarterly Sales of $6.92 Million
www.americanbankingnews.com - February 12 at 2:50 AM
Head to Head Contrast: STARPHARMA HOLD/S (SPHRY) versus Pieris Pharmaceuticals (PIRS)Head to Head Contrast: STARPHARMA HOLD/S (SPHRY) versus Pieris Pharmaceuticals (PIRS)
www.americanbankingnews.com - February 11 at 8:06 AM
-$0.16 Earnings Per Share Expected for Pieris Pharmaceuticals Inc (PIRS) This Quarter-$0.16 Earnings Per Share Expected for Pieris Pharmaceuticals Inc (PIRS) This Quarter
www.americanbankingnews.com - February 10 at 7:18 PM
Comparing US Stem Cell (USRM) and Pieris Pharmaceuticals (PIRS)Comparing US Stem Cell (USRM) and Pieris Pharmaceuticals (PIRS)
www.americanbankingnews.com - February 7 at 11:18 PM
Pieris Pharmaceuticals Inc (PIRS) Receives Consensus Recommendation of "Buy" from AnalystsPieris Pharmaceuticals Inc (PIRS) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - January 31 at 11:34 AM
What Kind Of Shareholder Appears On The Pieris Pharmaceuticals, Inc.’s (NASDAQ:PIRS) Shareholder Register?What Kind Of Shareholder Appears On The Pieris Pharmaceuticals, Inc.’s (NASDAQ:PIRS) Shareholder Register?
finance.yahoo.com - January 9 at 7:02 PM
Should You Buy Pieris Pharmaceuticals, Inc. (PIRS)?Should You Buy Pieris Pharmaceuticals, Inc. (PIRS)?
finance.yahoo.com - December 18 at 8:22 AM
How Much Did Pieris Pharmaceuticals Inc’s (NASDAQ:PIRS) CEO Pocket Last Year?How Much Did Pieris Pharmaceuticals Inc’s (NASDAQ:PIRS) CEO Pocket Last Year?
finance.yahoo.com - December 4 at 5:38 PM
Form 8-K PIERIS PHARMACEUTICALS, For: Nov 15Form 8-K PIERIS PHARMACEUTICALS, For: Nov 15
www.streetinsider.com - November 17 at 8:14 AM
Edited Transcript of PIRS earnings conference call or presentation 7-Nov-18 1:00pm GMTEdited Transcript of PIRS earnings conference call or presentation 7-Nov-18 1:00pm GMT
finance.yahoo.com - November 15 at 8:21 AM
Pieris Pharmaceuticals Q3 revenues up 113%Pieris Pharmaceuticals Q3 revenues up 113%
seekingalpha.com - November 7 at 5:47 PM
Pieris Pharmaceuticals (PIRS) PT Lowered to $5 at H.C. WainwrightPieris Pharmaceuticals (PIRS) PT Lowered to $5 at H.C. Wainwright
www.streetinsider.com - November 7 at 5:47 PM
Pieris Pharmaceuticals (PIRS) CEO Steve Yoder on Q3 2018 Results - Earnings Call TranscriptPieris Pharmaceuticals' (PIRS) CEO Steve Yoder on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 7 at 5:47 PM
Pieris Pharmaceuticals beats by $0.01, beats on revenuePieris Pharmaceuticals beats by $0.01, beats on revenue
seekingalpha.com - November 7 at 8:20 AM
Pieris Pharmaceuticals (PIRS) Reports Q3 Loss, Tops Revenue EstimatesPieris Pharmaceuticals (PIRS) Reports Q3 Loss, Tops Revenue Estimates
www.zacks.com - November 7 at 8:20 AM
Pieris Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate UpdatePieris Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - November 7 at 8:20 AM
Pieris Pharmaceuticals: 3Q Earnings SnapshotPieris Pharmaceuticals: 3Q Earnings Snapshot
finance.yahoo.com - November 7 at 8:20 AM
Pieris Pharmaceuticals to Host Third Quarter 2018 Investor Call and Corporate Update on November 7,Pieris Pharmaceuticals to Host Third Quarter 2018 Investor Call and Corporate Update on November 7,
www.nasdaq.com - October 31 at 8:21 AM
Pieris Pharmaceuticals to Host Third Quarter 2018 Investor Call and Corporate Update on November 7, 2018Pieris Pharmaceuticals to Host Third Quarter 2018 Investor Call and Corporate Update on November 7, 2018
finance.yahoo.com - October 31 at 8:21 AM
Pieris Pharmaceuticals Appoints Matthew L. Sherman, M.D., to its Board of DirectorsPieris Pharmaceuticals Appoints Matthew L. Sherman, M.D., to its Board of Directors
finance.yahoo.com - October 25 at 8:20 AM
Are Pieris Pharmaceuticals Inc’s (NASDAQ:PIRS) Interest Costs Too High?Are Pieris Pharmaceuticals Inc’s (NASDAQ:PIRS) Interest Costs Too High?
finance.yahoo.com - October 16 at 4:59 PM
New Research Coverage Highlights Dorian LPG, Avadel Pharmaceuticals, Pieris Pharmaceuticals, Resolute Energy, American Public Education, and THL Credit — Consolidated Revenues, Company Growth, and Expectations for 2018New Research Coverage Highlights Dorian LPG, Avadel Pharmaceuticals, Pieris Pharmaceuticals, Resolute Energy, American Public Education, and THL Credit — Consolidated Revenues, Company Growth, and Expectations for 2018
finance.yahoo.com - October 16 at 8:25 AM
Pieris Pharmaceuticals: Our Take On This $5 Biotech StockPieris Pharmaceuticals: Our Take On This $5 Biotech Stock
seekingalpha.com - October 10 at 5:02 PM
Pieris Pharmaceuticals to Present Preclinical Data for 4-1BB/PD-L1 Bispecific PRS-344/ONC0055 at the Society for Immunotherapy of Cancer (SITC) Annual MeetingPieris Pharmaceuticals to Present Preclinical Data for 4-1BB/PD-L1 Bispecific PRS-344/ONC0055 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
finance.yahoo.com - October 2 at 8:20 AM
Pieris Pharmaceuticals to Present at Investor Conferences in OctoberPieris Pharmaceuticals to Present at Investor Conferences in October
finance.yahoo.com - September 25 at 8:14 AM
Pieris Pharmaceuticals to Present Preclinical Data for Inhaled IL-4Ra Antagonist AZD1402/PRS-060 at the ERS International Congress 2018Pieris Pharmaceuticals to Present Preclinical Data for Inhaled IL-4Ra Antagonist AZD1402/PRS-060 at the ERS International Congress 2018
www.nasdaq.com - September 14 at 8:25 AM
Pieris Pharmaceuticals to Present Preclinical Data for Inhaled IL-4Rα Antagonist AZD1402/PRS-060 at the ERS International Congress 2018Pieris Pharmaceuticals to Present Preclinical Data for Inhaled IL-4Rα Antagonist AZD1402/PRS-060 at the ERS International Congress 2018
finance.yahoo.com - September 14 at 8:25 AM
Pieris Pharmaceuticals Appoints Peter Kiener, D.Phil. to its Board of DirectorsPieris Pharmaceuticals Appoints Peter Kiener, D.Phil. to its Board of Directors
finance.yahoo.com - September 10 at 8:19 AM
Dosing underway in Pieris Pharmas early-stage study of cancer candidate PRS-343; shares up 3%Dosing underway in Pieris Pharma's early-stage study of cancer candidate PRS-343; shares up 3%
seekingalpha.com - September 4 at 5:06 PM
Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 ImmunotherapyPieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy
finance.yahoo.com - September 4 at 8:25 AM
Pieris Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment ConferencePieris Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
finance.yahoo.com - August 30 at 8:29 AM
Edited Transcript of PIRS earnings conference call or presentation 9-Aug-18 12:00pm GMTEdited Transcript of PIRS earnings conference call or presentation 9-Aug-18 12:00pm GMT
finance.yahoo.com - August 24 at 5:08 PM
Pieris Pharmaceuticals reports Q2 resultsPieris Pharmaceuticals reports Q2 results
seekingalpha.com - August 10 at 5:24 PM
Pieris Pharmaceuticals. Inc (PIRS) CEO Stephen Yoder on Q2 2018 Results - Earnings Call TranscriptPieris Pharmaceuticals. Inc (PIRS) CEO Stephen Yoder on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 6:00 PM
Pieris Pharmaceuticals (PIRS) Reports Break-Even Earnings for Q2Pieris Pharmaceuticals (PIRS) Reports Break-Even Earnings for Q2
finance.yahoo.com - August 9 at 6:00 PM
Pieris Pharmaceuticals: 2Q Earnings SnapshotPieris Pharmaceuticals: 2Q Earnings Snapshot
finance.yahoo.com - August 9 at 8:28 AM
Pieris Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate UpdatePieris Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - August 9 at 8:28 AM
Pieris Pharmaceuticals to Present at the 2018 Wedbush PacGrow Healthcare ConferencePieris Pharmaceuticals to Present at the 2018 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 8 at 8:25 AM
Pieris Pharmaceuticals to Host Second Quarter 2018 Investor Call and Corporate Update on August 9, 2018Pieris Pharmaceuticals to Host Second Quarter 2018 Investor Call and Corporate Update on August 9, 2018
finance.yahoo.com - August 1 at 8:26 AM
Initiating Free Research Reports on Pieris Pharma and Three Other Biotech EquitiesInitiating Free Research Reports on Pieris Pharma and Three Other Biotech Equities
finance.yahoo.com - July 18 at 8:13 AM
Pieris Pharmaceuticals to Present at Jefferies 2018 Global Healthcare ConferencePieris Pharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference
finance.yahoo.com - May 31 at 8:28 AM
Should You Be Content With Pieris Pharmaceuticals Inc’s (NASDAQ:PIRS) Earnings Growth?Should You Be Content With Pieris Pharmaceuticals Inc’s (NASDAQ:PIRS) Earnings Growth?
finance.yahoo.com - May 21 at 8:16 AM
Form 8-K PIERIS PHARMACEUTICALS, For: May 10Form 8-K PIERIS PHARMACEUTICALS, For: May 10
www.streetinsider.com - May 12 at 5:53 PM
Edited Transcript of PIRS earnings conference call or presentation 10-May-18 12:00pm GMTEdited Transcript of PIRS earnings conference call or presentation 10-May-18 12:00pm GMT
finance.yahoo.com - May 11 at 8:28 AM
Pieris Pharmaceuticals (PIRS) CEO Stephen Yoder on Q1 2018 Results - Earnings Call TranscriptPieris Pharmaceuticals' (PIRS) CEO Stephen Yoder on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 5:56 PM
Pieris Pharmaceuticals misses by $0.15, misses on revenuePieris Pharmaceuticals misses by $0.15, misses on revenue
seekingalpha.com - May 10 at 8:25 AM
Pieris Pharmaceuticals: 1Q Earnings SnapshotPieris Pharmaceuticals: 1Q Earnings Snapshot
finance.yahoo.com - May 10 at 8:25 AM
Pieris Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate UpdatePieris Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - May 10 at 8:25 AM
Pieris Pharmaceuticals to Present at 43rd Annual Deutsche Bank Health Care ConferencePieris Pharmaceuticals to Present at 43rd Annual Deutsche Bank Health Care Conference
finance.yahoo.com - May 3 at 8:17 AM
Pieris Pharmaceuticals to Host First Quarter 2018 Investor Call and Corporate Update on May 10, 2018Pieris Pharmaceuticals to Host First Quarter 2018 Investor Call and Corporate Update on May 10, 2018
finance.yahoo.com - May 1 at 8:26 AM
This page was last updated on 2/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel